Cargando…
Transition from fresh frozen plasma to solvent/detergent plasma in the Netherlands: comparing clinical use and transfusion reaction risks
Plasma transfusion is indicated for replenishment of coagulative proteins to stop or prevent bleeding. In 2014, the Netherlands switched from using ~300mL fresh frozen plasma (FFP) units to using 200mL Omniplasma, a solvent/detergent treated pooled plasma (SD plasma), units. We evaluated the effect...
Autores principales: | Saadah, Nicholas H., Schipperus, Martin R., Wiersum-Osselton, Johanna C., van Kraaij, Marian G., Caram-Deelder, Camila, Beckers, Erik A.M., Leyte, Anja, Rondeel, Jan M.M., de Vooght, Karen M.K., Weerkamp, Floor, Zwaginga, Jaap Jan, van der Bom, Johanna G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109716/ https://www.ncbi.nlm.nih.gov/pubmed/31273090 http://dx.doi.org/10.3324/haematol.2019.222083 |
Ejemplares similares
-
Reported transfusion‐related acute lung injury associated with solvent/detergent plasma – A case series
por: Klanderman, Robert B., et al.
Publicado: (2022) -
Risk factors for bleeding in haemato-oncology patients—a nested case–control study: The BITE study protocol (Bleeding In Thrombocytopenia Explained)
por: Cornelissen, Loes L, et al.
Publicado: (2020) -
Association of Timing of Plasma Transfusion With Adverse Maternal Outcomes in Women With Persistent Postpartum Hemorrhage
por: Henriquez, Dacia D. C. A., et al.
Publicado: (2019) -
Thrombocytopenia and the effect of platelet transfusions on the occurrence of intracranial hemorrhage in patients with acute leukemia – a nested case-control study
por: Cornelissen, Loes L., et al.
Publicado: (2020) -
Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks
por: Cornelissen, Loes L., et al.
Publicado: (2021)